1. Keys to Cultural Integration

    That’s Nice sat down with Catherine Hanley, Alcami’s Director of Marketing, to find out how to successfully integrate after a merger.

  2. The Importance of Flexibility: Competitive Solutions in an Era of Innovation

    Nice Insight is in conversation with Uwe Harbauer, Senior Vice President, Pharma Business Unit, Bosch Packaging Technology, to discuss how equipment supplier/pharma company relationships have changed over time, including the growing importance of longer-term, more strategic interactions.

  3. FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.
    The company accelerates CDMO investment to boost its GMP capacity.
  4. Small Molecule Cancer Combination Therapy Receives Second Patent
    Combination of intralesional PV-10 with systemic immunomodulatory therapy to treat liver cancer granted US patent.
  5. Q: What do you see as being the most innovative technologies introduced in 2017? Why were they important? What impacts did they have?
    Experts weigh in our Roundtable questions.
  6. Vetter’s Opens a New Office in South Korea
    The company increases its presence in Asia.
  7. X-Ray and Inspection Solutions for Quality Control

    James Chrismas, International Pharmaceutical Business Manager for Loma Systems comments on finding contaminants—and missing products—through the company’s portfolio.

  8. Intrauterine Devices Offer New Benefit
    Study finds IUDs may protect against cervical cancer.
  9. Engineering Machines for Solid Dosage Forms and the Global Market
    Klaus Groschel, Managing Director Sales & Marketing, Xertecs comments on the company’s new lab units.
  10. What’s New in Granulation?

    Ed Godek, Manager of Process Technology at Glatt Air Techniques, discusses equipment trends including containment of high potency compounds.

  11. Building the Foundation of Japan’s Premier CDMO

    Jun Yokohama, President & CEO of Bushu Pharmaceuticals Ltd. and Toshio Yoshioka, President at Spera Pharma, Inc. discuss how the firm helps clients overcome barriers to entry.

  12. Analytical Method Development: Key to Process Development
    Helmut Schneider, Ph.D., Manager, Biopharmaceutical Technology-Analytical and Keith Webber Investigator, Biopharmaceutical Technology – Analytical at GSK Contract Manufacturing, explain the importance of analytical development activities.
  13. Compugen Advances Lead Anti-TIGIT Monoclonal Antibody to Manufacturing
    Anticipating its IND filing, company taps Bayer Healthcare for process development and manufacturing services.
  14. Moving Beyond Monoclonal Antibodies
    Next-generation antibody therapeutics are designed to provide improved specificity, efficacy and safety when compared to conventional monoclonal antibodies.
  15. Pharma’s Automation Index on the Rise
    Call it the automation of everything — a hands-off approach will permeate supply chains in the near future.
  16. First Treatment for Rare Blood Disorder Approved by FDA
    Kinase inhibitor’s approval accelerated by Priority Review, Breakthrough and Orphan Drug Designations.
  17. Batch to Continuous: Changing Customer Mindset

    Mike Barker, Sales Manager for L.B. Bohle discusses trends in the equipment sector.

  18. Novel Compound Developed That Could Serve as a Non-Addictive Opiod Alternative
    New compound enhances the brain’s ability to generate natural painkillers.
  19. Road To BIO: Coming Soon To Your Screen
    That’s Nice is producing a film based on the Road To BIO, for release in 2017. Watch the teaser trailer to get a taster of all the behind-the-scenes stories, character insights, and what went into the project.
  20. New Malaria Therapeutic Receives FDA Orphan Drug Designation
    Development accelerates for Artemis Therapeutic’s lead anti-viral, anti-parasitic candidate Artemisone.
Nice Insight Research
CDMO
Annual Study
A study of 163 CDMOs for use by both buyers and sellers of contract services with customer ratings
702 Respondents
313 Profiles
163 Deepdive
View Directory
CRO
Annual Study
Compare ratings for 73 CROs and clinical services providers to match buyer or seller needs
609 Respondents
124 Profiles
73 Deepdive
View Directory
Excipients
Annual Study
Learn customer needs directly from 541 respondents to ensure you meet them and gain sales
541 Respondents
39 Profiles
31 Deepdive
View Directory
OEM
Annual Study
Find out the most important factors in equipment purchasing from 597 customers for the year for (bio)processing
597 Respondents
137 Profiles
90 Deepdive
View Directory
Clinical Supply
Chain Annual Study
320 customers rate key factors in supporting an emerging global clinical supply chain model
320 Respondents
22 Profiles
22 Deepdive
View Directory
Intermediates
Annual Study
545 buyers reveal key factors in sourcing and purchasing pharmaceutical intermediates
545 Respondents
86 Profiles
62 Deepdive
View Directory
MOST VIEWED THIS MONTH
THE ROAD TO BIO: THE EXTENDED STORY
View All
For Your Listening Pleasure
The full story of this epic journey can be experienced as an audiobook. Listen to the story behind the story – the characters, the challenges, and all 12 days of the Road To BIO.
Pharma's Almanac TV
View All Video

Road To BIO: Coming Soon To Your Screen

That’s Nice is producing a film based on the Road To BIO, for release in 2017. Watch the teaser trailer to get a taster of all the behind-the-scenes stories, character insights, and what went into the project.

Facility Expansion at Abzena

John Manzello, President, US, Abzena

Attracting Investors and Shortening Development Times

James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)

Providing a Complete Modular Solution

George Wiker, Executive Director, AES

Drug Development

Vetter’s Opens a New Office in South Korea

Nov 17, 2017 8:04:00 AM PAO-M11-17-NI-032
Drug Development

Small Molecule Cancer Combination Therapy Receives Second Patent

Nov 17, 2017 8:02:00 AM PAO-M11-17-NI-031
Oncology

Intrauterine Devices Offer New Benefit

Nov 17, 2017 8:01:00 AM PAO-M11-17-NI-030
Investment

FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.

Nov 17, 2017 8:00:00 AM PAO-M11-17-NI-029
Drug Development

New Malaria Therapeutic Receives FDA Orphan Drug Designation

Nov 16, 2017 2:08:18 PM PAO-M11-17-NI-028
Drug Discovery

Novel Compound Developed That Could Serve as a Non-Addictive Opiod Alternative

Nov 16, 2017 2:04:26 PM PAO-M11-17-NI-027
FDA

First Treatment for Rare Blood Disorder Approved by FDA

Nov 16, 2017 2:00:40 PM PAO-M11-17-NI-026
Drug Development

Compugen Advances Lead Anti-TIGIT Monoclonal Antibody to Manufacturing

Nov 16, 2017 1:56:59 PM PAO-M11-17-NI-025
Strategic Partnership

QuintilesIMS Now IQVIA

Nov 14, 2017 2:39:09 PM PAO-M11-17-NI-024
Strategic Partnership

Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases

Nov 14, 2017 2:31:06 PM PAO-M11-17-NI-022
Clinical Research

CRO Pharmaceutical Product Development Wins NIH Contract for HIV Research

Nov 14, 2017 2:26:03 PM PAO-M11-17-NI-021
Acquisition

Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy

Nov 10, 2017 1:53:15 PM PAO-M11-17-NI-020
Expanded Capacity

AbbVie Starts Up New Mammalian Cell-Culture Production Facility in Singapore

Nov 10, 2017 1:53:06 PM PAO-M11-17-NI-019
Expanded Capacity

Eli Lilly Expands Insulin Production Capacity in Indiana

Nov 10, 2017 1:45:04 PM PAO-M11-17-NI-018
FDA

EMA, FDA Move Forward with Mutual Recognition of Inspections

Nov 10, 2017 1:30:45 PM PAO-M11-17-NI-017
CDMO

Alcami to Manufacture Darinaparsin

Nov 9, 2017 2:39:50 PM PAO-M11-17-NI-016
Innovation

London’s Science Museum Displays Breakthrough Stem Cell Sprayer

Nov 9, 2017 2:27:42 PM PAO-M11-17-NI-015
Drug Development

NIH Funds Bacterial DNA Superbug Killer

Nov 9, 2017 2:25:12 PM PAO-M11-17-NI-014
Research

Lung Cancer Research Institute Recipients Announced

Nov 9, 2017 2:22:30 PM PAO-M11-17-NI-013
Research

Fertility Experts: Embryos Travel Better Frozen

Nov 7, 2017 11:27:24 AM PAO-M11-17-NI-012
Clinical Data

Bariatric Surgery Demonstrates Effective Diabetes Control

Nov 7, 2017 11:22:31 AM PAO-M11-17-NI-011
Pregnancy Tracker

Ovarian Cycle Bracelet Detects Pregnancy in Trials

Nov 7, 2017 11:19:59 AM PAO-M11-17-NI-010
Drug Development

Amgen and Novartis Expand Collaboration to Prevent Alzheimer’s

Nov 7, 2017 11:16:53 AM PAO-M11-17-NI-009
Immuno-oncology

Immuno-oncology Approach Based on Electronic Circuitry

Nov 3, 2017 1:21:07 PM PAO-M11-17-NI-008
Partnership

Parexel and MicroSoft to Develop New Cloud Technology

Nov 3, 2017 1:18:33 PM PAO-M11-17-NI-007
Oncology

Intelligent Nanoparticles Kill Cancer Cells

Nov 3, 2017 1:10:35 PM PAO-M11-17-NI-005
Topical

New NSAID Topical Gels Penetrate Three Times Faster

Nov 2, 2017 3:21:28 PM PAO-M11-17-NI-004
CAR T

Mustang Bio Sends CAR T Cell Therapy Line to College

Nov 2, 2017 3:11:03 PM PAO-M11-17-NI-003
FDA

FDA, European Regulators Align for More Efficient GMP Inspections

Nov 2, 2017 3:07:38 PM PAO-M11-17-NI-002
FDA Approval

Calquence, AstraZeneca’s BTK Inhibitor Approved by FDA

Nov 2, 2017 3:00:42 PM PAO-M11-17-NI-001
Research

Studies Show Delayed Umbilical Cord Clamping Might be Key to Life Extension

Oct 31, 2017 2:46:12 PM PAO-M10-17-NI-048
FDA

Gene Therapy for Hemophilia A Granted Breakthrough Therapy Designation

Oct 31, 2017 2:38:20 PM PAO-M10-17-NI-047
Vaccine

New Initiative to Accelerate Development of Universal Flu Vaccines Launches

Oct 31, 2017 2:33:36 PM PAO-M10-17-NI-046
Acquistion

Novartis Plans Acquisition of Advanced Accelerator Applications for $3.9 Billion

Oct 31, 2017 2:29:01 PM PAO-M10-17-NI-045
Cell and Gene Therapy

Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics

PAP-Q4-17-CL-004
API

Achieving Efficient Pharmaceutical Synthesis with Process Intensification

PAP-Q3-17-CL-003
Columns

Virtual Panel

ADCs: The Future of Biologic Drugs
The contract manufacturing market for antibody-drug conjugates has huge potential, but an extraordinary range of capabilities is essential to be in the game. We spoke to some of the players to find out all about ADCs.

Roundtable

Innovative Technologies

Design Logic

Marken: Stronger Than Ever
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.
//Fix for text overflow in cards